Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cutler

Showing results (441-450 of 915) with videos related to

Pageof 92
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 25, 2026
Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension studySuresh Durgam, Willie R Earley, Susan G Kozauer, et al.
Parasitology Research|November 30, 2000
Equine protozoal myeloencephalitis: mystery wrapped in enigmaJ B Dame, T J Cutler, S Tanhauser, et al.
Journal of Psychosomatic Research|January 1, 1989
Psychophysiological factors in ventricular arrhythmias and sudden cardiac deathD C Hatton, E R Gilden, M E Edwards, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Annual costs among patients with major depressive disorder and the impact of key clinical eventsAndrew J Cutler, Katelyn R Keyloun, Sara Higa, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|December 12, 2022
Association of medication-assisted treatment and short acting opioids with newborn head circumference and birth weightAnya J Cutler, David F Cox, Sarah M B Gabrielson, et al.
Osteoarthritis and Cartilage|June 9, 2018
An observational analysis of discontinuation and non-publication of osteoarthritis trialsJ Scott, C M Cooper, J X Checketts, et al.
Journal of Clinical Psychopharmacology|July 2, 2025
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity DisorderGregory W Mattingly, Osman Turkoglu, Denise Chang, et al.
Nature Immunology|April 17, 2020
Author Correction: Approaches and advances in the genetic causes of autoimmune disease and their implicationsJamie R J Inshaw, Antony J Cutler, Oliver S Burren, et al.
Natural Product Communications|September 8, 2009
Phytochemical characterization of the leaves of Mitragyna speciosa grown in U.S.AFrancisco León, Eman Habib, Jessica E Adkins, et al.
Peptides|February 17, 2001
Orexin-A immunoreactive neurons in the rat hypothalamus do not contain neuronal nitric oxide synthase (nNOS)D J Cutler, R Morris, M L Evans, et al.
Pageof 92

Showing results (441-450 of 915) with videos related to

Sort By:
Pageof 92
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 25, 2026
Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension studySuresh Durgam, Willie R Earley, Susan G Kozauer, et al.
Parasitology Research|November 30, 2000
Equine protozoal myeloencephalitis: mystery wrapped in enigmaJ B Dame, T J Cutler, S Tanhauser, et al.
Journal of Psychosomatic Research|January 1, 1989
Psychophysiological factors in ventricular arrhythmias and sudden cardiac deathD C Hatton, E R Gilden, M E Edwards, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2022
Annual costs among patients with major depressive disorder and the impact of key clinical eventsAndrew J Cutler, Katelyn R Keyloun, Sara Higa, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|December 12, 2022
Association of medication-assisted treatment and short acting opioids with newborn head circumference and birth weightAnya J Cutler, David F Cox, Sarah M B Gabrielson, et al.
Osteoarthritis and Cartilage|June 9, 2018
An observational analysis of discontinuation and non-publication of osteoarthritis trialsJ Scott, C M Cooper, J X Checketts, et al.
Journal of Clinical Psychopharmacology|July 2, 2025
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity DisorderGregory W Mattingly, Osman Turkoglu, Denise Chang, et al.
Nature Immunology|April 17, 2020
Author Correction: Approaches and advances in the genetic causes of autoimmune disease and their implicationsJamie R J Inshaw, Antony J Cutler, Oliver S Burren, et al.
Natural Product Communications|September 8, 2009
Phytochemical characterization of the leaves of Mitragyna speciosa grown in U.S.AFrancisco León, Eman Habib, Jessica E Adkins, et al.
Peptides|February 17, 2001
Orexin-A immunoreactive neurons in the rat hypothalamus do not contain neuronal nitric oxide synthase (nNOS)D J Cutler, R Morris, M L Evans, et al.
Pageof 92